Publications by authors named "Thomas Mclaughlin"

Claim this Profile
T
The First Pilot Epigenetic Type Improvement of Neuropsychiatric Symptoms in a Polymorphic Dopamine D2 (-DRD2/ANKK (Taq1A)), OPRM1 (A/G), DRD3 (C/T), and MAOA (4R) Compromised Preadolescence Male with Putative PANDAS/CANS: Positive Clinical Outcome with Precision-Guided DNA Testing and Pro-Dopamine Regulation (KB220) and Antibacterial Therapies.
Kenneth Blum, Igor Elman, David Han, Colin Hanna, David Baron, Thomas McLaughlin

Open J Immunol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Complex NADASE Infusions Improve Clinical Outcome in Substance Use Disorder: Descriptive Annotation in Fifty Cases.
Kenneth Blum, Thomas Mclaughlin, Kai Uwe Lewandrowski, Alireza Sharafshah, Catherine Dennen

J Addict Psychiatry· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Solving the Global Opioid Crisis: Incorporating Genetic Addiction Risk Assessment with Personalized Dopaminergic Homeostatic Therapy and Awareness Integration Therapy.
Foojan Zeine, Nicole Jafari, David Baron, Abdalla Bowirrat, Albert Pinhasov, Thomas McLaughlin

J Addict Psychiatry· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary Document Research on RDS Anti-addiction Modeling: Annotated Bibliography.
Kenneth Blum, David Baron, Thomas McLaughlin, Panayotis K Thanos, Catherine Dennen

J Addict Psychiatry· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Identification of stress-induced epigenetic methylation onto dopamine D2 gene and neurological and behavioral consequences.
Kenneth Blum, Abdalla Bowirrat, David Baron, Igor Elman, Milan T Makale, Thomas McLaughlin

Gene Protein Dis· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Are We Getting High Cause the Thrill is Gone?
Kenneth Blum, Thomas Mclaughlin, Mark S Gold, Marjorie C Gondre-Lewis, Panayotis K Thanos

J Addict Psychiatry· December 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Neurogenetics and Epigenetics of Loneliness.
Abdalla Bowirrat, Igor Elman, Catherine A Dennen, Marjorie C Gondré-Lewis, Jean Lud Cadet, Thomas J McLaughlin

Psychol Res Behav Manag· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dopaminergic dysfunction: Role for genetic & epigenetic testing in the new psychiatry.
Kenneth Blum, J Wesson Ashford, Babak Kateb, Daniel Sipple, Eric Braverman, Thomas McLaughlin

J Neurol Sci· October 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Invited Expert Opinion- Bioinformatic and Limitation Directives to Help Adopt Genetic Addiction Risk Screening and Identify Preaddictive Reward Dysregulation: Required Analytic Evidence to Induce Dopamine Homeostatsis.
Kenneth Blum, Mark S Gold, Jean Lud Cadet, Marjorie C Gondre-Lewis, Thomas McLaughlin

Med Res Arch· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The Future is Now for Precision Genomic Addiction Medicine as a Frontline Modality for Inducing "Dopamine Homeostasis" in Reward Deficiency Syndrome (RDS).
Elizabeth D Gilley, Abdalla Bowirrat, Ashim Gupta, John Giordano, Catherine A Dennen, Thomas McLaughlin

Curr Pharm Biotechnol· April 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Futuristic Thinking about Engineering "Geneospirituality" to Help Prevent Relapse of Reward Deficiency Syndrome (RDS) Behaviors.
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, Debasis Bagchi, Eric R Braverman

EC Psychol Psychiatr· February 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Future Newborns with Opioid-Induced Neonatal Abstinence Syndrome (NAS) Could Be Assessed with the Genetic Addiction Risk Severity (GARS) Test and Potentially Treated Using Precision Amino-Acid Enkephalinase Inhibition Therapy (KB220) as a Frontline Modality Instead of Potent Opioids.
Mauro Ceccanti, Kenneth Blum, Abdalla Bowirrat, Catherine A Dennen, Eric R Braverman, Thomas Mclaughlin

J Pers Med· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
W
Why haven't we solved the addiction crisis?
Kenneth Blum, Abdalla Bowirrat, Luis Llanos Gomez, B William Downs, Debasis Bagchi, Thomas McLaughlin

J Neurol Sci· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
"
"Preaddiction" construct and reward deficiency syndrome: genetic link via dopaminergic dysregulation.
Kenneth Blum, Igor Elman, Catherine A Dennen, Thomas McLaughlin, Panayotis K Thanos

Ann Transl Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Addiction Risk Severity Assessment Identifies Polymorphic Reward Genes as Antecedents to Reward Deficiency Syndrome (RDS) Hypodopaminergia's Effect on Addictive and Non-Addictive Behaviors in a Nuclear Family.
Catherine A Dennen, Kenneth Blum, Abdalla Bowirrat, Panayotis K Thanos, Igor Elman, Thomas McLaughlin

J Pers Med· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should Reward Deficiency Syndrome (RDS) Be Considered an Umbrella Disorder for Mental Illness and Associated Genetic and Epigenetic Induced Dysregulation of Brain Reward Circuitry?
Kenneth Blum, Catherine A Dennen, Igor Elman, Abdalla Bowirrat, Panayotis K Thanos, Thomas McLaughlin

J Pers Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Genetic Addiction Risk and Psychological Profiling Analyses for "Preaddiction" Severity Index.
Kenneth Blum, David Han, Abdalla Bowirrat, Bernard William Downs, Debasis Bagchi, Thomas McLaughlin

J Pers Med· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reward Deficiency Syndrome (RDS) Surprisingly Is Evolutionary and Found Everywhere: Is It "Blowin' in the Wind"?
Kenneth Blum, Thomas McLaughlin, Abdalla Bowirrat, Edward J Modestino, David Baron

J Pers Med· February 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Review of DNA Risk Alleles to Determine Epigenetic Repair of mRNA Expression to Prove Therapeutic Effectiveness in Reward Deficiency Syndrome (RDS): Embracing "Precision Behavioral Management".
Kenneth Blum, Bruce Steinberg, Marjorie C Gondre-Lewis, David Baron, Edward J Modestino, Thomas McLaughlin

Psychol Res Behav Manag· December 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Endorphinergic Enhancement Attenuation of Post-traumatic Stress Disorder (PTSD) Activation of Neuro-immunological Function in the Face of a Viral Pandemic.
Kenneth Blum, Edward J Modestino, David Baron, Raymond Brewer, Panayotis Thanos, Thomas McLaughlin

Curr Psychopharmacol· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A prospective study to compare serial changes in pain scores for patients with and without a history of frequent ED utilization.
Ryan Joseph, Alainya Tomanec, Thomas McLaughlin, Jose Guardiola, Peter Richman

Heliyon· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Novel Precision Approach to Overcome the "Addiction Pandemic" by Incorporating Genetic Addiction Risk Severity (GARS) and Dopamine Homeostasis Restoration.
Kenneth Blum, Shan Kazmi, Edward J Modestino, Bill William Downs, Debasis Bagchi, Thomas McLaughlin

J Pers Med· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Should We Embrace the Incorporation of Genetically Guided "Dopamine Homeostasis" in the Treatment of Reward Deficiency Syndrome (RSD) as a Frontline Therapeutic Modality?
Kenneth Blum, Ali Raza, Tiffany Schultz, Rehan Jalali, Richard Green, Thomas McLaughlin

Acta Sci Neurol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Epigenetic Repair of Terrifying Lucid Dreams by Enhanced Brain Reward Functional Connectivity and Induction of Dopaminergic Homeostatic Signaling.
Kenneth Blum, Thomas McLaughlin, Edward J Modestino, David Baron, Abdalla Bowirrat

Curr Psychopharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Exploration of Epigenetic State Hyperdopaminergia (Surfeit) and Genetic Trait Hypodopaminergia (Deficit) During Adolescent Brain Development.
Kenneth Blum, Abdalla Bowirrat, Marjorie C Gondre Lewis, Thomas A Simpatico, Mauro Ceccanti, Thomas McLaughlin

Curr Psychopharmacol· February 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis